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Estimating a Preference-Based Index for Mental Health From the
Recovering Quality of Life Measure: Valuation of Recovering Quality of
Life Utility Index
Anju Devianee Keetharuth, PhD, Donna Rowen, PhD, Jakob Bue Bjorner, PhD, John Brazier, PhD
A B S T R A C T
Background: There are increasing concerns about the appropriateness of generic preference-based measures to capture health
benefits in the area of mental health.
Objectives: The aim of this study is to estimate preference weights for a new measure, Recovering Quality of Life (ReQoL-10),
to better capture the benefits of mental healthcare.
Methods: Psychometric analyses of a larger sample of mental health service users (n = 4266) using confirmatory factor an-
alyses and item response theory were used to derive a health state classification system and inform the selection of health
states for utility assessment. A valuation survey with members of the UK public representative in terms of age, sex, and region
was conducted using face-to-face interviewer administered time-trade-off with props. A series of regression models were
fitted to the data and the best performing model selected for the scoring algorithm.
Results: The ReQoL-Utility Index (UI) classification system comprises 6 mental health items and 1 physical health item. Sixty-
four health states were valued by 305 participants. The preferred model was a random effects model, with significant and
consistent coefficients and best model fit. Estimated utilities modeled for all health states ranged from 20.195 (state
worse than dead) to 1 (best possible state).
Conclusions: The development of the ReQoL-UI is based on a novel application of item response theory methods for
generating the classification system and selecting health states for valuation. Conventional time-trade-off was used to
elicit utility values that are modeled to enable the generation of QALYs for use in cost-utility analysis of mental health
interventions.
Keywords: mental health, preference-based measure, QALYs, ReQoL-10, ReQoL-20.
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Introduction
Quality adjusted life years (QALYs), a composite measure
combining quality of life and duration of life, are used in cost-
effectiveness analyses. Typically, the quality of life component of
the QALY is generated using an off-the-shelf generic or condition-
specific preference-based measure. The most commonly used
generic preference-based measure, EQ-5D, has a focus on physical
health (PH) with only 1 of the 5 dimensions directly pertaining to
mental health (MH). There is growing evidence that EQ-5D is not
well suited for use in certain areas of MH,1-4 raising the question
as to whether another preference-based measure with a larger
focus on MH that also includes physical health, would be more
appropriate for use in cost-effectiveness analyses in those areas.
Such a measure may have the advantage of performing better
psychometrically, as it may be better able to detect changes in MH
over time and differences across treatments. In addition, the
measure would be more relevant for and acceptable to people for
inclusion in data collection with MH problems.
The Recovering Quality of Life (ReQoL) measures, ReQoL-10
and ReQoL-20, were developed for people aged #16 years old
experiencing a broad range of mental health difficulties from
common mental health problems to more severe psychotic ones.5
They are intended for use in routine practice with people expe-
riencing mental health difficulties and can be used to evaluate
interventions for this population. ReQoL-10 contains 10 MH items
and ReQoL-20, 10 additional items. Both versions contain a PH
item (see Appendix 1 in Supplemental Materials found at https://
doi.org/10.1016/j.jval.2020.10.012). The theoretical framework
underpinning the themes for the measures were established from
a qualitative literature review and in-depth interviews.1,6,7 Six MH
themes (activity; belonging; choice, control and autonomy; hope;
self-perception; and well-being) and a theme relating to PH were
identified. Psychometric evidence generated through 2 studies
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recruiting more than 6500 service users8,9 was combined with the
qualitative evidence10 to select items for the final measures.11
The aim of this article is to present the derivation of ReQoL
utility index (ReQoL-UI), a recovery-focused generic preference-
based measure derived from ReQoL-10 and ReQoL-20. It pre-
sents the development of a novel approach because standard
methods used to select health states for valuation rely on inde-
pendence between dimensions, which is not present between the
MH items in ReQoL-UI.
Methods
ReQoL-UI was constructed in 4 stages: (1) the derivation of the
classification system of ReQoL-UI; (2) the choice of health states
for valuation using item response theory (IRT); (3) the time trade-
off valuation (TTO) survey used to elicit values for a selection of
ReQoL-UI health states; and (4) the modeling of preference
weights that can be used to generate utility values for all health
states defined by the ReQoL-UI.
ReQoL Data for Use in Stages 1 and 2
Data were gathered from 4266 individuals accessing MH ser-
vices from primary (27%) and secondary care (67%), from a trial
cohort for a depression study (5%) and from the voluntary sector
(1%). The sample is described in detail elsewhere.5,9 In summary,
58% of the sample was female, the age range was 16 to 98 and
mean (SD) age was 47 (17) years. Respondents self-reported a
wide range of diagnoses including common MH disorders (51%)
and psychotic disorders (18%).
Stage 1: Development of the ReQoL-UI Classification
System
The aim of this stage is to generate a health state classification
system amenable for valuation. The 10 ReQoL-10 MH items and
the PH item were therefore considered for the reduced classifi-
cation system as these items also appear in ReQoL-20. However,
the use of all the 11 items to elicit preference weights during the
valuation exercise would be cognitively too onerous.12 To maintain
the face validity of the ReQoL-10 measure, we chose 1 item from
each of the 6 MH themes and the PH item, all being identified as
important to services users experiencing MH difficulties. To select
the MH items, we adopted the following steps: (1) consider the
dimensionality of the ReQoL item set; (2) exclude any misfitting
item(s); (3) select items with the best psychometric properties.
For step (1) confirmatory factor analysis was undertaken using
MPlus 7.3.13 Model fit was assessed using root mean square error
approximation and comparative fit index. In a bifactor model
providing an adequate fit, the negatively (n = 24) and positively
worded items (n = 15) loaded onto a “negative” factor and a
“positive” factor, respectively.9 However, the explained common
variance of the global factor was 85% suggesting the measure
could be appropriately analyzed using unidimensional IRT models.
To undertake steps (2) and (3), the graded response IRT model
was fitted to the 39 items to estimate item parameters and the full
results are presented elsewhere (see Keetharuth et al8 for full
results). The graded IRT model expresses the probability of a
particular response to a ReQoL item as a function of item char-
acteristics (item discrimination and item thresholds) and a latent
mental health variable (theta [q]), which is assumed to have a
standard normal distribution (with high scores indicating good
mental health). Based on the graded response model, q can be
estimated for each respondent and the contribution of each item
to the overall measurement precision at a given q level can be
assessed through Fisher information functions.14 For various levels
of q scores ranging from 22 to 2 in intervals of 0.4, the ReQoL-10
items were ranked in order of the item’s contribution to mea-
surement precision. This approach ensured that the most infor-
mative items were chosen and that the items covered the range
of severity observed among MH service users. IRT analyses were
carried out using IRTPRO 3.1.15
Stage 2: Selecting Health States
Standard approaches for selecting health states (eg, orthogonal
arrays) for valuation, rely on independence between dimensions,
which is not the case in ReQoL-UI. Previous studies where the
classification system has a unidimensional component with
correlated items have used a Rasch vignette approach.16,17 The
latter approach uses Rasch-based threshold analysis to select
commonly observed health states for valuation, and then gener-
ates utility values for all possible health states using a regression
model that predicts TTO utilities using the Rasch score for the
health state. Here, we adapted this approach to IRT methods
rather than Rasch analysis because IRT models have been shown
to provide a good description of the ReQoL items,8 and IRT pro-
vides more flexibility in modeling than Rasch analysis.
We selected health states for valuation choosing the response
combinations that are most likely to be encountered in practice by
estimating the probability of each possible combination of health
states according to the graded response model. We performed
such calculations across the entire range of estimated q values
from 22.18 (worst score on all 6 items) to 1.85 (best scores on the
chosen 6 items). To achieve a reasonable trade-off between
complexity and detail, we categorized this range into 15 score
groups: score group 1 through 8 covered the range from 22.18 to
0, while score group 9 through 15 covered the range from 0 to
1.85. For each score group, the response combinations providing a
score within this range were ranked according to their probability
and the 3 most likely response combinations were chosen as
health states for valuation (see Appendix Fig. 1 in Supplemental
Materials found at https://doi.org/10.1016/j.jval.2020.10.012). For
score group 15, only one response combination (555555) provided
a score in this range, so this score group only contributed one
health state (for a total of 14*311=43 health states). To ensure
accurate utility assessment of poor MH states, we purposively
oversampled response combinations providing a MH score below
the average. For each of the 8 score groups below 0, we selected 2
additional response combinations for a total of 59 MH states
(4318*2). These were combined with the PH item by randomly
selecting one physical level to be considered together with the MH
states (using the random number generator in Excel). Five addi-
tional combinations of PH and MH states were added. For mental
health, these included the worst possible MH score (555555), the
best possible score (111111), and a score indicating “average” MH
(333333). This approach was chosen because MH and PH form 2
separate dimensions and appear separately in the regression an-
alyses undertaken in stage 4. All items were scaled from 1 to 5
with level 5 indicating the worst PH or MH (highest level of
impact).
Stage 3: Design and Conduct of the Valuation Study
People’s preferences for the sample of health states previously
selected were elicited using TTO, a choice-based technique, in
face-to-face interviews with members of the UK public. Based on
similar valuation studies, we intended to recruit around 300
participants.18 Respondents were selected to generate a nationally
representative sample based on age and sex from postcodes in
Scotland, England, and Wales. Households in the selected areas
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received a letter in advance, advising them that an interviewer
would call, with an opportunity to opt out. Interviews were
managed by a market research agency and were conducted by
experienced interviewers trained by the researchers. Face-to-face
training was provided to all interviewers by 2 experienced re-
searchers. First, an overview of the task was presented. Second,
the interviewers were familiarized with the health state classifi-
cation. Third, role-play in pairs provided each interviewer with an
opportunity to interview someone else and be interviewed. Each
interviewer was assigned a supervisor who could answer any
questions and provide support; preliminary data checks were also
carried out by the agency. Interviews were held in the re-
spondents’ own home and respondents were offered £10 for their
participation.
During the interview, respondents first completed de-
mographic and health questions followed by the ReQoL-10 to
familiarize themselves with the health state classification system
and response options. The interviewer told the participants that
the health states were made up using statements from the ques-
tions you had just seen. Second, respondents undertook a warm-
up task in the form of a practice TTO question. The interviewer had
the discretion to decide whether a second practice question was
necessary. Third, respondents undertook TTO valuation of 8
different health states. The Measurement and Valuation of Health
protocol and its related props were used for states better than
dead,19 and lead-time TTO was used for states worse than dead.20
This approach is the composite time trade-off approach that is in
accordance with the protocol used internationally to value the EQ-
5D-5L, that was developed to resolve the issue that previous TTO
protocols required an arbitrary rescaling of states valued worse
than dead.21 Respondents were first asked whether they would
prefer to live in the health state to be valued for 10 years and then
die, or to die immediately to establish whether the health state
was better, worse, or equal to being dead. For health states better
than dead, participants were asked to imagine they would be in
the health state that was being valued for a period of 10 years.
They were then asked to consider a number of shorter periods in
full health (x) to ascertain how many years of full health the
respondent was willing to give up to avoid being in the impaired
health state that was being valued. At the point where re-
spondents were indifferent between x years in full health and 10
years in the state, the state took the value x/10. For states worse
than dead, lead-time TTO was used which involves the same
approach but adds a lead-time of 10 years to both full health and
the impaired health state to allow respondents to trade these 10
years to avoid the impaired health state.20 The state took the
value 2y/10, where y is the number of lead-time years that the
respondent is prepared to sacrifice to avoid the impaired health
state. Finally, respondents rated how difficult they found the tasks,
and interviewers rated how well they thought the respondent had
understood and engaged with the task.
Stage 4: Modeling Health State Preferences
The ReQoL-UI MH items form a unidimensional MH compo-
nent, with the PH item constituting a second dimension. There-
fore, similar to the modeling approach used in the Rasch vignette
approach,22 TTO values were regressed on the IRT-based MH score
(estimated through the expected a posteriori approach) and
dummy variables to represent 4 of the severity levels of the PH
item (with level 1 as the reference case). The expected a posteriori
estimates (q) were rescaled from a range of 22.18 to 1.85 to a scale
of 0 (best possible mental health) to 1 (worst possible mental
health). Different regression models were fitted using mean and
individual level data including a simple linear relationship,
quadratic and cubic relationships. First, model specifications
included mean level ordinary least squares (OLS) where mean
scores were regressed on the rescaled q scores and on dummy
variables for the levels of the PH item. To account for multiple
observations per individuals we also estimated random effects
(RE) models23 using maximum likelihood estimation. The error
term εij ¼ uj 1 eij where uj is the random effect and eij repre-
sents the random error term for the ith health state valuation of
the jth individual.
Table 1. Evaluation of most informative item by each score level.
q Item information functions Most informative item on each score level ranked by
iteration
ACT1 ACT5P* BEL2* BEL3P CHO4* HOP1P HOP4* SEL2P* WB11P* Iteration
1
Iteration
2
Iteration
3
Iteration
4
Iteration
5
22 0.703 1.034 0.700 0.648 0.923 0.578 1.305 0.410 0.749 HOP4* ACT5P* CHO4 WB11P ACT1
21.6 0.953 1.571 1.143 0.731 2.319 0.868 2.109 0.976 1.576 CHO4* HOP4 WB11P ACT5P BEL2*
21.2 1.077 1.753 1.443 0.764 3.251 1.065 2.413 1.731 2.159 CHO4 HOP4 WB11P ACT5P SEL2P
20.8 1.114 1.783 1.537 0.778 3.373 1.133 2.475 2.081 2.179 CHO4 HOP4 WB11P SEL2P ACT5P
20.4 1.124 1.745 1.560 0.784 3.370 1.154 2.455 2.140 2.277 CHO4 HOP4 WB11P SEL2P ACT5P
0 1.124 1.735 1.562 0.785 3.402 1.157 2.145 2.158 2.231 CHO4 WB11P SEL2P HOP4 ACT5P
0.4 1.120 1.821 1.519 0.779 3.271 1.166 1.330 2.187 2.304 CHO4 WB11P SEL2P ACT5P BEL2
0.8 1.098 1.800 1.323 0.754 2.283 1.160 0.581 2.203 2.284 WB11P* CHO4 SEL2P ACT5P BEL2
1.2 1.027 1.534 0.913 0.685 0.897 1.084 0.211 1.968 2.184 WB11P SEL2P* ACT5P HOP1P ACT1
1.6 0.833 0.961 0.495 0.554 0.262 0.874 0.071 1.269 1.536 WB11P SEL2P ACT5P HOP1P ACT1
2 0.554 0.458 0.231 0.393 0.070 0.579 0.023 0.581 0.716 WB11P SEL2P HOP1P ACT1 ACT5P
The following were not selected: ACT1 “I found it hard to get started with everyday task,” BEL3P “I felt able to trust others,” HOP1P “I felt hopeful about my future.” The
remaining tenth item “I could do the things I wanted to do” was a misfitting item.
*Most informative items chosen for the health state classification system: ACT5P “I enjoyed what I did,” BEL2 “I felt lonely,” CHO4 “I felt unable to cope,” HOP4 “I thought
my life was not worth living,” SEL2P “I felt confident in myself,” and WB11P “I felt happy.”
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Where i = 1,2 . n represents the individual health states and j =
1,2.m represents the respondents. The dependent variable ysij is
disutility (1-TTO) for health state i valued by respondent j and q
represents IRT scores for the corresponding health state, X is a
vector of dummy explanatory variables for each level l of the PH
items with level l = 1 acting as a baseline. All models excluded a
constant because we used full health as defined by ReQoL-UI level
1111111 as our upper anchor for TTO.24 We explored the inclusion
of interaction terms that interacted the severity of the MH
component, q, with the PH dimension, where, as health worsens
the interaction term increases. We estimated consistent models,
where adjacent inconsistent levels of the physical dimension were
merged, to ensure that as health worsened the utility value would
not increase. All modeling was performed using STATA 15.25
Model Performance
Several criteria were used to evaluate model performance: (1)
inconsistencies in parameter estimates and significance of co-
efficients; (2) comparing predictive model performance using root
mean square error (RMSE), mean absolute error (MAE), difference
between actual and predicted values at health state level, per-
centage of observations with absolute errors (AE) .0.05 and .0.1;
and plots of actual and predicted health state values; (3)
comparing Akaike Information Criterion (AIC) and Bayesian In-
formation Criterion (BIC) for different model specifications within
the same types of models.
Compliance With Ethical Standards
Ethical approval for stages 1 and 2 was granted by the Edg-
baston National Research Ethics Services committee, West Mid-
lands (14/WM/1062). Ethical approval for the valuation survey
was obtained from the School of Health and Related Research via
the University of Sheffield Research Ethics Committee process
(reference number: 009307). Informed consent was obtained from
all respondents in the study.
Results
Stage 1: Health State Classification System
Table 1 reports analyses of the ReQoL-10 items, using the IRT
results. One item “I could do the things I wanted to do” was
excluded as it was misfitting, indicating that standard IRT scoring
may not be appropriate for this item. Through ranking the
remaining 9 items in order of highest information across different
severity levels for mental health, 5 items were first selected; items
providing the most information at the highest severity levels
were: “I thought my life was not worth living,” and “I felt unable to
cope,” and “I enjoyed what I did”; the items providing the most
information at the low severity end were: “I felt happy” and “I felt
confident in myself.” To ensure that each theme was represented,
a sixth item from the belonging theme, “I felt lonely” was chosen
even though it was the fifth best item at both the severe and
milder ends. The selected items were rephrased to the present
tense (Table 2).
Stage 2: Selecting Health States
The method described above yielded 59 health states for
valuation (see Appendix Table 1 in Supplemental Materials found
at https://doi.org/10.1016/j.jval.2020.10.012). The additional 5
health states provided the opportunity to add the pits state
“5555555” as the best state was already selected. Two other states
were selected so that more severe levels of physical impairment
were combined with the best MH state to isolate the impact of PH
more clearly; and finally, a moderate severity state was added.
Stage 3: Design and Conduct of the Valuation Study
Valuation survey participants
Based on similar studies, we recruited 305 participants.18 In-
terviews were carried out by 15 experienced and trained in-
terviewers each undertaking between 5 and 30 interviews. The
proportion of total suitable participants answering their door at the
timeof the interviewwas28%. Five participantswere excluded from
the analysis: 4 valued all health states as identical and less than 1,
implying they did not understand the task; one valued all health
states as worse than dead, implying that the participant thought
that no statewas worth living. The characteristics of the sample are
compared with the population from England andWales (Table 3).
Forty-eight respondents (16%) reported a MH condition, out of
whom 35 were receiving treatment. The 3 most reported MH
conditions were anxiety, depression, and stress-related (including
posttraumatic stress disorder). One hundred respondents (34%)
reported a physical problem with the 3 most reported conditions
being high blood pressure, tiredness and fatigue, and pain. Only 5
(2%) and 29 (10%) respondents reported that they found the
questions very difficult and quite difficult to understand, respec-
tively. Interviewers noted that 5 (2%) respondents had not quite
understood the questions; that 17 respondents (6%) did not
concentrate very hard and had put little effort into the valuation
task and that 2 respondents (,1%) concentrated at the beginning
but subsequently lost concentration or interest. Interviews lasted
34 minutes on average (SD = 10).
Health State Values
The number of observations per state vary from 27 to 44. The
distribution of observed TTO values show that 21%, 4%, and 6% of
observations at 1, 0, and 21, respectively (see Appendix Fig. 2 in
Supplemental Materials found at https://doi.org/10.1016/j.jval.202
0.10.012). The mean observed TTO values by health state range
from 20.178 (worst state = 5455555) to 0.966 (best state =
1111111). A measure-specific full health value below 1 is expected
because the state is compared to “full health,” which may be
imagined by participants to be better than the state described. In
the first 3 states (see Appendix Table 1 in Supplemental Materials
found at https://doi.org/10.1016/j.jval.2020.10.012), it is evident
that as PH severity increases, the mean TTO value falls. The worst
health state (5555555) has higher mean TTO (20.128) than the
state 5455555 (20.178) and state 5553554 (20.144), but it should
be noted that different respondents valued these health states.
Stage 4: Modeling the Health State Utility Data to
Generate Utility Values for All Health States
The best performing mean linear and quadratic OLS and RE
models, assessed in terms of MAE, RMSE, AIC, BIC, and observa-
tions with AE greater than 0.1 and 0.05 are presented in Table 4.
The RE models were preferred to fixed effects models using the
Hausman test. There were some inconsistent coefficients in the
linear models for levels 2 and 3 of PH compared with level one.
The coefficients for the quadratic models were all in the direction
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expected, where increasing severity leads to decreases in utility,
with the exception of the interaction terms combining level 2 of
PH and q (compared with level 1) for both OLS and RE model 2,
where the coefficient was positive rather than negative (for linear
and quadratic RE complete model results, see Appendix Tables 2
and 3 in Supplemental Materials found at https://doi.org/10.1
016/j.jval.2020.10.012). The cubic models are not presented as
they do not provide a monotonous decreasing utility scores for
worse MH (see Appendix Tables 4 and 5 in Supplemental
Materials found at https://doi.org/10.1016/j.jval.2020.10.012). We
present a summary comparison of the models in Appendix Table 6
in Supplemental Materials found at https://doi.org/10.1016/j.jval.2
020.10.012. The best performing mean level OLS model (model 2)
and RE models (model 6) consist of a quadratic specification of q
with interaction terms for q and levels 3, 4, and 5 of PH. They have
the lowest RMSE, lowest AIC and BIC, and lowest percentage of
observations with AE ,0.1 and 0.05. The interaction terms in all
models are negative. As shown in Figure 1 and Appendix Figure 3
in Supplemental Materials found at https://doi.org/10.1016/j.jval.2
020.10.012, neither models exhibit systematic bias in the pre-
dictions by severity for the majority of health states except for the
most severe states where larger prediction errors were observed.
RE model 6 is the overall preferred model because it had better
predictive ability, albeit only slightly better than the OLS model
Table 2. ReQoL descriptive system.
Theme Description of health states Levels
1. Activity (act5p: I enjoyed what I did) I enjoy what I do most or all of the time 1
I often enjoy what I do 2
I sometimes enjoy what I do 3
I only occasionally enjoy what I do 4
I never enjoy what I do 5
2. Belonging and relationships (bel2: I felt lonely) I never feel lonely 1
I only occasionally feel lonely 2
I sometimes feel lonely 3
I often feel lonely 4
I feel lonely most or all of the time 5
3. Choice, control and autonomy (cho4: I felt unable to cope) I never feel unable to cope 1
I only occasionally feel unable to cope 2
I sometimes feel unable to cope 3
I often feel unable to cope 4
I feel unable to cope most or all of the time 5
4. Hope (hop4: I thought my life was not worth living) I never think that my life is not worth living 1
I only occasionally think that my life is not worth living 2
I sometimes think my life is not worth living 3
I often think my life is not worth living 4
Most or all of the time I think my life is not worth living 5
5. Self-perception (sel2p: I felt confident in myself) I feel confident in myself most or all of the time 1
I often feel confident in myself 2
I sometimes feel confident in myself 3
I only occasionally feel confident in myself 4
I never feel confident in myself none of the time 5
6. Wellbeing (wb11p: I felt happy) I feel happy most or all of the time 1
I often feel happy 2
I sometimes feel happy 3
I only occasionally feel happy 4
I never feel happy 5
7. Physical health item (please describe your physical health:
problems with pain, mobility, difficulties caring for yourself,
or feeling physically unwell)
I have no problems with physical health 1
I have slight problems with physical health 2
I have moderate problems with physical health 3
I have severe problems with physical health 4
I have very severe problems with physical health 5
-- 5
Table 3. Characteristics of respondents in the valuation survey.
Mean SD Range England and Wales
norms
Age 51.6 19.1 18-96 39*
Life satisfaction score 8.0 1.8 2-10 7.5†
Health satisfaction score 7.7 2.0 1-10
n Percentage (%) England and Wales
norms‡ (%)
Sex Male 135 45.0 49.1
Female 164 54.7 50.9
Other 1 0.3
Marital Status Single 67 22.3 34.6
Married/partner 161 53.7 46.6
Separated/divorced 26 8.7 11.6
Widowed 45 15.0 7.0
Prefer not to say 1 0.3
Ethnicity White 278 92.7 86.0
Asian/Asian British 16 5.3 7.5
Black/African/Caribbean/Black British 3 1.0 3.3
Other ethnic group 3 1.0 3.2
Degree Yes 87 29.0 27.0
No 202 67.3
Missing 11 3.7
Main activity Employed 146 48.7 61.7
Retired 97 32.3 13.9
Housework 22 7.3 4.3
Student 5 1.7 9.3
Unemployed 16 5.3 4.4
Long-term sick 8 2.7 4.3
Other 6 2.0 2.2
Overall health Excellent 34 11.3
Very good 126 42.0
Good 96 32.0
Fair 31 11.4
Poor 10 3.3
Missing 1 0.3
Age categories, y 16-25 20 6.7 11.9%
26-64 173 57.7 52.8%
$65 84 28.0 16.4%
Missing 23 7.7
Experienced serious
illness yourself
Yes 83 27.7
No 211 70.3
Missing 6 2.0
Experienced serious
illness in the family
Yes 143 47.7
No 149 49.7
Missing 8 2.7
Experienced serious
illness in caring for others
Yes 77 25.7
No 215 71.7
Missing 8 2.7
How well interviewer thought the
respondent understood and carried
out the TTO tasks during the
interview? (answered by interviewers)
Understood and performed exercises easily 192 63.37
Some problems but seemed
to understand the exercises in the end
106 34.98
Doubtful whether the respondent
understood the exercises
5 1.65
Level of concentration
and effort of the respondent
as perceived by the interviewer
Concentrated very hard and put in a great
deal of effort
143 47.19
Concentrated fairly hard and put in
some effort
140 46.20
Did not concentrate very hard and put
in little effort into it
18 5.94
Concentrated at the beginning but
lost interest/concentration toward the end
2 0.66
*Median age only was found.
†Office of National Statistics life satisfaction 2016.
‡Statistics for England in the Census 2011. The census includes persons aged $16 years, whereas this study only surveys persons aged $18 years.
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when comparing the lowest proportion of absolute errors greater
than 0.05 and 0.1. The estimates for the best health state and worst
states are 1 and 20.195, respectively. Depicting the mean TTO
predicted by model 6 for levels 2 to 5 of PH indicate that the
decrements for the first 2 levels of the PH item are very similar,
with by far the largest gap being between levels 3 and 4 of
physical functioning (Fig. 2).
Discussion
We developed the ReQoL-UI health classification, which com-
prises 6 MH and 1 PH item from ReQoL-10 (and ReQoL-20) and
have produced a set of preference weights. An algorithm has been
estimated to generate the ReQoL-UI scores and available in STATA,
SPSS, and Excel, using the predictions from the preferred RE model
with the corresponding q for all the possible combinations for the
7 items. The preference weights enable utility values to be
generated from the ReQoL measures for use in cost-effectiveness
analyses across the full severity range of MH conditions. ReQoL-
10 and ReQoL-20 were specifically developed with considerable
inputs from service users and have high face and content val-
idity.10,11,26 Therefore, the corresponding utilities are likely to be
more appropriate for use to evaluate mental healthcare in-
terventions than those generated from generic preference-based
measures with a larger focus on PH rather than on MH.
Table 4. Regression results for estimating health preference scores.
OLS mean models Random effects models
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
(preferred)
Model 7
Linear with
interactions
Quadratic
with
interactions
Quadratic with
interactions, only
significant
coefficients
Linear with
interactions
Quadratic
with
interactions
Quadratic
with
interactions
Quadratic with
interactions, only
significant
coefficients
q (newtheta) 20.433* 0.01 20.053 20.441* 0.028 0.028 20.015
q2 (newthetasq) 20.572* 20.517* 20.582* 20.581* 20.558*
Phy2 0.059 20.069 0.089 20.033 20.032
Phy3 0.001 20.073 20.084* 0.027 20.050 20.049 20.076*
Phy4 20.140† 20.284* 20.270* 20.141* 20.265* 20.265* 20.261*
Phy5 20.189* 20.294* 20.284* 20.201* 20.292* 20.292* 20.288*
Inter2 20.099 0.066 20.151 0.002
Inter3 20.135 20.037 20.165 20.067 20.067
Inter4 20.503* 20.292* 20.293* 20.492* 20.310* 20.310* 20.292*
Inter5 20.501* 20.362* 20.356* 20.465* 20.350* 20.351* 20.330*
Constant‡ 1 1 1 1 1 1 1
Observations 64 64 64 2303 2303 2303 2303
Adjusted R-
squared
0.974 0.982 0.982
RMSE 0.082 0.067 0.069 0.082 0.069 0.069 0.070
MAE 0.069 0.056 0.058 0.069 0.057 0.057 0.057
AIC 2121 2144 2147 3451 3430 3428 3426
BIC 2102 2122 2132 3514 3499 3492 3477
No. of
observations
with AE .0.1
15 9 8 13 8 8 10
Percentage of
observations
with AE .0.1
23% 14% 13% 20% 13% 13% 16%
No. of
observations
with AE .0.05
42 32 33 39 29 29 32
Percentage of
observations
with AE .0.05
66% 50% 52% 61% 45% 45% 50%
q indicates IRT theta rescaled to 0 (best possible mental health score) and 1 (worst possible mental health scores); AE, absolute error; AIC, Akaike Information Criterion;
BIC, Bayesian Information Criterion; inter4 = q * phy4 inter5 = q * phy5; MAE, mean absolute error; phy2, level 2 physical health (phy1, best physical health and phy5,
worst); phy3, level 3 physical health; phy4, level 4 physical health; phy5, level 5 physical health; RMSE, root mean square error.
*P,.01.
†P,.05.
‡The models did not have a constant but a constant 1 is presented here so the coefficients can be presented as utility decrement.
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Although MAE is higher than some other TTO valuation studies
where error is in the region of 0.05,27,28 it is possible that this is
due to the different model specification estimated here that does
not differentiate between the different MH items in terms of their
differential impact on utility. Both the mean OLS models and the
RE models have good predictive ability across the range of utility
values, with predictive performance lowest for all models for the
very severe states. The poorer predictive performance for the
models for the more severe states may have been observed due to
the inconsistencies in the TTO utility values for some of the more
severe states, where worst state had a similar but slightly higher
mean TTO value than 2 other severe health states. Because the
value set that generates utility values for all health states is based
on modeled values, all utility values are logically consistent where
utility either remains the same or is lower as the health state
becomes more severe.
Figure 1. Plot of predicted versus observed utility values for the random effects (RE) model 6. ReQoL-UI indicates Recovering Quality of
Life Utility Index; TTO, trade-off valuation.
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Unlike the EQ-5D, 6 of the items form a unidimensional
component in the ReQoL-UI classification system related to MH,
with one dimension for PH. From the regression results, the
importance attributed to both PH and MH is clear. In the preferred
RE model, more than 50% of the utility decrement is attributed to
the severity of the MH condition compared with 23% for the worst
level (level 3) of anxiety and depression in the EQ-5Q-3L prefer-
ence weights.19 There is a possibility that this may be in part either
due to a framing effect or due to the number of MH items in the
classification system proportional to the number of PH items.
However, previous research has shown that all aspects of health in
a classification system do not always receive a sizable utility
decrement (see for example ‘appetite’ in EORTC QLU-C10D UK
weights29 or ‘worried’ in CHU9D UK weights),30 meaning that the
presence of an item alone does not guarantee a utility decrement,
nor does it follow that the larger the number of dimensions the
lower the utility values for the health state. Nonetheless, the PH
item has a large utility decrement of 0.29 for the most severe level.
One key advantage of including the PH item is that a utility
decrement is generated for PH as well as for mental health, and as
our qualitative research showed PH should not be ignored for
people with MH problems.7,10 In all the models, the signs of the
interaction terms are negative and highly significant. This finding
means that association between poor MH (q) and low utility
values is stronger when there is a moderate to severe PH problem.
This article provides an innovative use of IRT to select items
and health states for a preference-based classification system. It
improves the credibility of the states selected for valuation
compared to the use of statistical designs such as an orthogonal
array that can generate states with unlikely combinations of levels
across dimensions. Several articles have used item threshold
based on Rasch analysis to construct such a health classification
system,16,17 but, to our knowledge, none have used analyses of
response combination probabilities. This approach allowed us to
choose the health states that are more likely to be observed in real
life. We selected 59 MH states and this constitutes a clear
advantage since the larger number of health states included in this
valuation study provides for a more robust regression model
compared with previous applications of this approach. We
analyzed response combination based on the graded response IRT
model, but the approach could also be applied with the Rasch
model. Although the models are very similar, IRT models may fit a
broader set of scales.
There are a number of potential concerns to the article. First,
we only recruited 305 participants in the valuation survey.
Although the sample size for TTO valuation studies carried out
online tend to be much larger, several studies have similar or less
participants.18,31 The number of observations per state ranged
from 27 to 44, which is lower than 100 recommended.32 With 64
health states valued and each participant valuing 8 health states,
interviewing 800 participants face-to-face, would have been
prohibitive in terms of time and costs. A second set of concerns
surround the spike in the TTO data at 0, 1, and21. The spike at 1 is
due to the classification system where some people may not be
prepared to trade life years for at least some of the health states.
The spike at 0 reflects that people would rather die than be in the
impaired ReQoL-UI state, but are not prepared to sacrifice prior
years of full health to avoid any time in the impaired health state.
The spike at 21 is however caused by the TTO task because this is
the lowest utility that respondents can provide in the task, and
hence it may have been that for some respondents for some health
states they would have expressed a lower utility value if they had
been able.
Another concern raised with valuation of attributes that may
be more condition-specific or symptomatic is possible focusing
effects, where respondents can exaggerate their impact on utility
as these have not been placed within the context of other symp-
toms or more generic aspects of health.33,34 However, in this study
the attributes are not condition-specific but rather focused on MH,
and furthermore respondents considered PH problems alongside
MH problems, which arguably may have minimized focusing ef-
fects on MH.
The ReQoL-UI can be used in cost effectiveness analyses to
capture the utility impact of problems in MH. The choice of
preference-based measures to inform policy is one that is debated,
as many reimbursement agencies recommend the use of a generic
preference-based measure, often citing a recommended mea-
sure.34 For example, in the UK, the National Institute for Health
and Care Excellence recommends the use of one particular mea-
sure, the EQ-5D for use in cost-effectiveness analyses for health
technology assessment.35 However, alternative preference-based
measures can be used in sensitivity analyses and where it can
be evidenced that EQ-5D is not valid for the condition or patient
population of interest. ReQoL-UI has the advantage, compared
with other generic preference-based measures for use in people
with MH problems, that it was developed with considerable input
from MH service users and has 6 items capturing mental health.
Generic preference-based measures such as EQ-5D focus on PH
while including MH, whereas ReQoL-UI is arguably a generic
preference-based measure that focuses upon MH, while including
PH. Although this can provide an advantage for the evaluation of
MH interventions, the introduction of a measure, such as ReQoL-
UI with a different focus can cause issues of comparability
across evaluations undertaken in PH and MH, particularly if EQ-5D
or another generic preference-based measure is used for PH and
ReQoL-UI for MH. However, comparability in evaluations across
interventions can be maintained if EQ-5D is used in base case
analyses, and ReQoL-UI or other measures are used in sensitivity
analyses. Future research will empirically test the use of the
ReQoL-UI in trials and studies, including comparison with
preference-based generic measures including EQ-5D and SF-6D to
compare their relative psychometric performance, and also
explore the suitability of mapping to enable easier comparisons of
evaluations conducted using the different measures.
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